Claudia Manini1,2, Igone Imaz3, Aitor Fernández de Larrinoa3, José I López4. 1. Department of Pathology, San Giovanni Bosco Hospital, 10154, Turin, Italy. 2. Department of Sciences of Public Health and Pediatrics, University of Turin, 10124, Turin, Italy. 3. Department of Pathology, Cruces University Hospital, 48903, Barakaldo, Spain. 4. Biomarkers in Cancer Unit, Biocruces-Bizkaia Health Research Institute, Plaza de Cruces s/n, 48903, Barakaldo, Bizkaia, Spain. jilpath@gmail.com.
Abstract
PURPOSE OF REVIEW: A growing number of tumor entities with badly defined limits are enlarging in the last years the family of oncocytic tumors in the kidney. RECENT FINDINGS: Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are classically well-known tumors, but the borderland between them, and their precise connection, remains a matter of debate. Aside from that, other emerging and provisional entities, like eosinophilic solid and cystic renal cell carcinoma (ESC RCC), eosinophilic vacuolated tumor (EVT), low-grade oncocytic tumor (LOT), and papillary renal neoplasm with reverse polarity (PRRP), have been recently described. This spectrum of tumors remains a diagnostic challenge in renal pathology, especially if the specimen obtained is scarce. This review focuses on practical diagnostic problems when managing core biopsies and proposes a diagnostic algorithm maximizing the information provided by both morphology and immunohistochemistry. So, a combination of morphologic features on hematoxylin-eosin and six antibodies (CK7, CD117, CK20, CD10, GATA-3, and cathepsin K) is advised to be used in a stepwise fashion.
PURPOSE OF REVIEW: A growing number of tumor entities with badly defined limits are enlarging in the last years the family of oncocytic tumors in the kidney. RECENT FINDINGS: Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are classically well-known tumors, but the borderland between them, and their precise connection, remains a matter of debate. Aside from that, other emerging and provisional entities, like eosinophilic solid and cystic renal cell carcinoma (ESC RCC), eosinophilic vacuolated tumor (EVT), low-grade oncocytic tumor (LOT), and papillary renal neoplasm with reverse polarity (PRRP), have been recently described. This spectrum of tumors remains a diagnostic challenge in renal pathology, especially if the specimen obtained is scarce. This review focuses on practical diagnostic problems when managing core biopsies and proposes a diagnostic algorithm maximizing the information provided by both morphology and immunohistochemistry. So, a combination of morphologic features on hematoxylin-eosin and six antibodies (CK7, CD117, CK20, CD10, GATA-3, and cathepsin K) is advised to be used in a stepwise fashion.
Authors: Maria Pané Foix; Ana Dunatov; Petr Martinek; Enric Condom Mundó; Saul Suster; Maris Sperga; Jose I Lopez; Monika Ulamec; Stela Bulimbasic; Delia Perez Montiel; Reza Alaghehbandan; Kvetoslava Peckova; Krystina Pivovarcikova; Daum Ondrej; Pavla Rotterova; Faruk Skenderi; Kristyna Prochazkova; Martin Dusek; Milan Hora; Michal Michal; Ondrej Hes Journal: Virchows Arch Date: 2016-09-15 Impact factor: 4.064
Authors: Marta Salido; Josep Lloreta; Carme Melero; Mar García; José Placer; Blanca Espinet; Olaya Villa; Oscar Bielsa; Antoni Gelabert-Mas; Sergi Serrano; Francesc Solé Journal: Cancer Genet Cytogenet Date: 2005-12
Authors: Jiri Kolar; Andrea Feu Llaurado; Monika Ulamec; Faruk Skenderi; Delia Perez-Montiel; Isabel Alvarado-Cabrero; Stela Bulimbasic; Maris Sperga; Maria Tretiakova; Adeboye O Osunkoya; Joanna Rogala; Eva Comperat; Viliam Gal; Ana Dunatov; Kristyna Pivovarcikova; Kvetoslava Michalova; Adriena Bartos Vesela; Maryna Slisarenko; Andrea Peterikova Strakova; Tomas Pitra; Milan Hora; Michal Michal; Reza Alaghehbandan; Ondrej Hes Journal: Ann Diagn Pathol Date: 2022-05-20 Impact factor: 2.134
Authors: Shilpy Joshi; Denis Tolkunov; Hana Aviv; Abraham A Hakimi; Ming Yao; James J Hsieh; Shridar Ganesan; Chang S Chan; Eileen White Journal: Cell Rep Date: 2015-11-19 Impact factor: 9.423